Benzinga | Dec 7, 2021 05:09PM EST

Avid Bioservices: Q2 Earnings Insights

Avid Bioservices (NASDAQ:CDMO) reported its Q2 earnings results on Tuesday, December 7, 2021 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Avid Bioservices beat estimated earnings by 200%, reporting an EPS of $0.06 versus an estimate of $0.02, which surprised analysts.

Revenue was up $5,045,000 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.06, which was followed by a 12.05% drop in the share price the next day.

Here's a look at Avid Bioservices's past performance:



Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021EPS Estimate 0.04 -0.03 -0.06EPS Actual 0.10 -0.04 0.01 0.01Revenue Estimate 27.81M 21.60M 19.07M 15.49MRevenue Actual 30.75M 27.61M 21.81M 21.06M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.